sorafenib
sorafenib is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand names including Sorafenib, sorafenib, Nexavar. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- sorafenib
- Brand Names
- Sorafenib, sorafenib, Nexavar
- Application Number
- ANDA217095
- Sponsor
- Torrent Pharmaceuticals Limited
- NDC Codes
- 10
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- SORAFENIB, SORAFENIB TOSYLATE
Indications and Usage
Sorafenib tablets are a kinase inhibitor indicated for the treatment of Unresectable hepatocellular carcinoma(1.1) Locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DTC) refractory to radioactive iodine treatment (1.3) 1.1 Hepatocellular Carcinoma Sorafenib tablets are indicated for the treatment of patients with unresectable hepatocellular carcinoma (HCC). 1.3 Differentiated Thyroid Carcinoma Sorafenib tablets are indicated for the treatment of patients with locally recurrent or metastatic, progressive,differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment.